Items Tagged ‘Head and Neck Cancer’

November 28th, 2016

Opdivo Approved for Advanced Head and Neck Cancer

By

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  the indication is for the treatment of squamous cell carcinoma of the head and neck cancer (SCCHN) that has spread to distant sites in the body and has progressed or […]

View full entry

Tags: fda, General Head and Neck Cancer, Head and Neck Cancer, News, nivolumab, opdivo, schhn


October 5th, 2016

PET/CT Combined More Effective Than MRI in Monitoring Head and Neck Cancer Patients’ Response to Treatment

By

According to a recent study, combining PET/CT to monitor response to treatment in head and neck cancer patients appears more effective than MRI. Using PET/CT may better inform doctors whether treatment for head and neck cancer is working after just one cycle of chemotherapy. The ability to identify a patients response to chemotherapy early is […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, INSIGHT trial, MRI, News, PET/CT, squamous cell carcinoma


September 7th, 2016

Keytruda® Approved for Advanced Head and Neck Cancer

By

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding to platinum-based chemotherapy agents.1 Globally, head and neck cancer comprises the seventh most common type of cancer with an estimated 400,000-600,000 diagnoses every year. Head and neck squamous cell cancer […]

View full entry

Tags: advanced, fda, General Head and Neck Cancer, Head and Neck Cancer, keytruda, metastatic, News, pembrolizumab


June 9th, 2016

Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer

By

Patients with head and neck cancer who comply with their scheduled radiation treatments have significantly improved outcomes compared to those who miss 2 or more of their appointments within the prescribed time period. These results were recently published in the International Journal of Radiation Oncology, Biology, Physics. Head and neck cancer refers to several different […]

View full entry

Tags: appointments, General Head and Neck Cancer, Head and Neck Cancer, HNC, News, radiation, schedule


June 8th, 2016

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer

By

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO). Globally, head and neck cancer comprises the seventh most common type of cancer with an […]

View full entry

Tags: advanced, ASCO 2016, General Head and Neck Cancer, Head and Neck Cancer, HNSCC, KEYNOTE-012, keytruda, metastatic, News, perbrolizumab, squamous cell cancer


June 6th, 2016

Follow-Up Scans Reduce Need for Some Invasive Surgeries in Head and Neck Cancer

By

Utilizing PET-CT scans following treatment for patients with head and neck cancer that has spread to their lymph nodes significantly reduces the need for invasive follow-up surgery. These results were recently published in the New England Journal of Medicine. Patients diagnosed with head and neck cancer (HNC) that has spread to nearby lymph nodes are […]

View full entry

Tags: chemoradiation, General Head and Neck Cancer, Head and Neck Cancer, HNC, lymph nodes, News, PET-CT scans, surgery


May 25th, 2016

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer

By

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous cell carcinoma. These results prompted the United States Food and Drug Administration to grant Opdivo “breakthrough therapy designation” for the treatment of patients with […]

View full entry

Tags: Breakthrough Therapy Designation, CheckMate 141 clinical trial, fda, General Head and Neck Cancer, Head and Neck Cancer, News, nivolumab, opdivo, squamous cell


June 30th, 2015

Better Outcomes in Oral Cancer with Surgery to Remove Lymph Nodes in Neck before Cancer Spreads

By

In early squamous-cell oral cancer, surgery to remove lymph nodes in the neck before cancer spreads may result in better outcomes. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the New England Journal of Medicine. Oral cancer refers to cancer […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, lymph nodes, neck dissection, News, oral cancer, squamous cell


June 8th, 2015

Keytruda® Promising in Advanced Head and Neck Cancer

By

The immunotherapy Keytruda® (pembrolizumab) appears active in the treatment of advanced squamous cell head and neck cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical Oncology.[i] Head and neck cancers originate in the tissues in or […]

View full entry

Tags: Head and Neck Cancer, keytruda, News, pembrolizumab


April 2nd, 2015

Medical and dental centers throughout U.S. will take part in 18th annual OHANCAW®, April 12-18

By

NEW YORK, NY, march 24, 2015 – Donnie Walsh, former President of the Indiana Pacers and New York Knicks and an oral cancer survivor, is urging Americans to get screened for cancer during the 18th annual Oral, Head & Neck Cancer Awareness Week® (OHANCAW®), being held nationwide April 12-18. More than 200 sites throughout the […]

View full entry

Tags: awareness week, General Head and Neck Cancer, Head and Neck Cancer, News, OHANCAW, OHNC


December 19th, 2014

Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer

By

More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer,  developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, ktp laser, News, vocal cord cancer


December 18th, 2013

USPSTF Issues Final Recommendation on Oral Cancer Screening

By

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendation regarding screening for oral cancer. The task force issued an “I” statement, which means there is not enough evidence to make a definitive recommendation for or against screening. The recommendation was published online in the Annals of Internal Medicine. Screening refers to looking […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, News


October 7th, 2013

Swallowing Exercises and Oral Nutrition Are Critical During Treatment for Oral Cancer

By

Patients with oral cancers who receive oral nutrition and practice swallowing exercises throughout their treatment are able to maintain a significantly better long-term diet, according to the results of a study published in JAMA Otolaryngology Head and Neck Surgery. Oropharyngeal cancer is a type of head and neck cancer. The oropharynx is the part of […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, News


September 16th, 2013

End-of-Life Care Remains Aggressive, Despite Patient Wishes

By

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive intensive treatment until the last month of life and hospice care is often delayed until the final three […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, HIV Related Cancers


August 2nd, 2013

Adding Vectibix to Cisplatin/Fluorouracil Improves Progression-Free Survival in Recurrent or Metastatic Head and Neck Cancer

By

The addition of Vectibix® (panitumumab) to cisplatin/fluorouracil as first-line treatment improves progression-free survival in patients with recurrent or metastatic head and neck cancer, according to the results of a study published in The Lancet Oncology. Head and neck cancers originate in the tissues in or around the mouth, nose, and throat. Risk factors for head […]

View full entry

Tags: General Head and Neck Cancer, Head and Neck Cancer, News